The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices
 

Oncolytics Biotech Inc

TSX: ONC
Delayed quote

$0.57

Today's change-0.01 -1.72%
Updated October 20 3:59 PM EDT. Delayed by at least 15 minutes.
 

Oncolytics Biotech Inc

TSX: ONC
Delayed quote

$0.57

Today's change-0.01 -1.72%
Updated October 20 3:59 PM EDT. Delayed by at least 15 minutes.

Oncolytics Biotech Inc down $0.01

Oncolytics Biotech Inc closed sharply lower Friday, dropping $0.01 or 1.72% to $0.57. Shares have lost 5.00% over the last five days, but have gained 115.09% over the last year to date. This security has outperformed the S&P TSX by 68.59% during the last year.

Key company metrics

  • Trailing P/ENegative, not meaningful
  • P/E 1 year forwardNegative, not meaningful
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS-$0.13
Updated October 20 3:59 PM EDT. Delayed by at least 15 minutes.
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2017Q1/2017Q4/2016Q3/2016
Fiscal Quarter Endvalues in $ millions unless otherwise notedJun 30, 201706/30/2017Mar 31, 201703/31/2017Dec 31, 201612/31/2016Sep 30, 201609/30/2016
Revenue--------
Total other revenue--------
Total revenue0000
Gross profit--------
Total cost of revenue--------
Total operating expense4453
Selling / general / administrative0000
Research & development3232
Depreciation / amortization0000
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total1121
Operating income-4-4-5-3
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax-4-4-5-3
Income after tax-4-4-5-3
Income tax, total0000
Net income-4-4-5-3
Total adjustments to net income--------
Net income before extra. items-4-4-5-3
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items-4-4-5-3
Inc. avail. to common incl. extra. items-4-4-5-3
Diluted net income-4-4-5-3
Dilution adjustment--0--0
Diluted weighted average shares127121121121
Diluted EPS excluding extraordinary itemsvalue per share-0.03-0.03-0.04-0.03
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share-0.03-0.03-0.04-0.03